Compare Datadog Inc (DDOG) vs Revvity Inc (RVTY) Price & Performance

Datadog (DDOG) trades at $293.26, up 8.08% in the last session, showing strong momentum with consistent earnings beats in recent quarters. The stock exhibits bullish technical signals with moving averages supporting upward trends, while fundamentals reveal robust revenue growth from $2.7B in 2024 to $3.4B in 2025. Recent news highlights accelerating AI and enterprise customer expansion, with FBN Securities initiating coverage with an Outperform rating.

Investment outlook remains positive given strong analyst consensus (83% buy ratings) and accelerating AI-driven growth, though elevated valuation ratios (P/E 547.6, P/S 25.33) pose risks if growth moderates. Key risks include competitive pressure in cloud monitoring and dependence on enterprise spending cycles. The stock trades above the $276.10 consensus target, suggesting near-term upside may be limited despite bullish sentiment.

Revvity (RVTY) trades at $154.18, up 0.38% today and near its 52-week high of $158.28. The stock shows a bullish technical trend with strong moving averages and has beaten earnings estimates for the last three quarters. Recent developments include the launch of a new diabetes screening kit in Europe and the acquisition of Human Cell Design to expand its metabolic disease research tools. Revenue remains stable around $2.9 billion, though net income margin is modest at 8.16%.

The outlook is positive with analyst consensus leaning buy (51.72%) and a price target of $132.13, though the current price exceeds it. Key opportunities include diagnostic growth and AI-driven demand, while risks involve premium valuation (P/E 73.15), margin pressures, and exposure to China market volatility. Earnings on November 3, 2026, will be critical for near-term direction.